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DOI 10.1016/j.str.2007.10.006In 2000, NIH began funding a program
called the Protein Structure Initiative,
or PSI. PSI has been controversial
since its creation was first discussed,
and as I contemplate PSI today I find
myself humming the fine old Gershwin
tune, ‘‘Lets Call the Whole Thing Off.’’
PSI remains the bad idea it always
was, and I am not alone in regarding
it so (Petsko, 2007). However, given
the number of people both inside and
outside NIH who have a stake in its
continuation, PSI is unlikely to go
away anytime soon, and those foolish
enough to argue for its abolition are li-
able to find themselves losing friends
while failing to influence people.
The PSI is a large, centralized pro-
gram focused on protein structure de-
termination that not only emulates the
HumanGenomeProject, but was stim-
ulated by it. By the late 1990s, in no
small measure because of the success
of the Human Genome Project, protein
sequences began accumulating in da-
tabases far faster than protein struc-
tures could be solved. Furthermore,
the labor, cost, and uncertainties con-
nected with protein structure determi-
nation being what they were—and still
are—it seemed unlikely the structural
biology community would ever ‘‘catch
up’’. Consequently, some began argu-
ing that an enterprise similar in scale to
the Human Genome Project should be
launched to industrialize the determi-
nation of protein structures. If this
were done, the argument went, the se-
quence-structure ‘‘gap’’ would quickly
close, and the impact on medicine and
biology would rival that of the Human
Genome Project. NIH responded by
establishing the Protein Structure Ini-
tiative (PSI), and today, as the second
cycle of PSI grants are being awarded,
NIH supports 10 centers at a cost of1350 Structure 15, November 2007 ª200about $60,000,000 a year. Enthusiasm
for structural genomics is not limited to
the United States; similar centers exist
in other countries.
The long-term objective of PSI is,
‘‘.to make the three-dimensional
structures of most proteins easily




htm). Implicit in this objective is the
notion that we do not need to solve
the structure of every single protein
on the planet experimentally, a Sisy-
phean task if there ever was one.
The proponents of PSI point out that
the number of different tertiary folds
found in protein domains is many or-
ders of magnitude smaller than the
number of different protein domains,
as determined by sequence, which is
true. They then argue that if high reso-
lution structures were obtained for
protein domains representing every
fold class it would then be possible
to compute the structure of all other
protein domains whose sequences are
known by homology modeling. Thus
if PSI were to produce the requisite
catalog of domain structures using
the high-throughput experimental
structure determination methods it de-
velops, computational biochemists
would take care of the rest, and un-
told amounts of time and effort would
be saved. Unfortunately, at the pre-
sent time, there is no evidence that
that protein models accurate enough
to be useful biochemically can be de-
rived from sequences by homology
modeling or by any other computa-
tional means.
In thinking about the rationale for PSI,
it is useful to ask who wants/needs
high resolution protein structures7 Elsevier Ltd All rights reservedin the first place, because not every-
one does. Thousands of cell and mo-
lecular biologists take the view that
once all the macromolecules involved
in some process have been identified
and one-line descriptions obtained
for their functions, you know all you
need to know. They feel that way for
reason; a lot of biology can be under-
stood at that level. Only the minority
that needs/wants to understand the
chemistry responsible for the proper-
ties of macromolecules finds atomic
resolution macromolecular structures
essential. (NB: It does not follow that
high resolution structures lack value!
On the contrary, much that is of the
greatest importance for both public
health and for biology can be obtained
from high resolution structures.)
It also important to ask whether
computation of protein structures
from protein sequences by homology
modeling is a realistic goal, even if it
does not happen to be feasible today.
In the end, all macromolecular struc-
tures are models, and it is already pos-
sible to compute three-dimensional
models for macromolecules starting
from their sequences. The problem
with these models is that they are nei-
ther useful nor reliable. In order for
a molecular model to be fully useful
in a chemical sense, it must specify
the positions of individual nonhydro-
gen atoms with errors on the order of,
say, 0.5 A˚
´
or less, and a reliable model
is one in whose accuracy its users can
trust. In my book, only models that are
useful and reliable deserve to be called
‘‘structures,’’ and I have yet to be
shown a nontrivial protein model com-
puted from sequence alone that qual-
ifies. To put it another way, if your lab-
oratory were to begin an investigation
that depended on your knowledge of
Structure
Opiniona protein’s structure and all you had
was a structural model for it computed
from its sequence, wouldn’t you begin
by determining its structure experi-
mentally? I submit that you would be
crazy if you did not.
In fact, all the useful, reliable models
for macromolecules we have today,
i.e., all macromolecular structures,
have been obtained by techniques
that, however they work, end up by
finding that fold of a macromolecule’s
sequence which is most consistent
both with a large body of experimental
data that has been obtained about that
particular macromolecule either by
crystallography or by NMR, and with
what is known about the geometry of
organic molecules more generally.
(For the record, most of what we
know about molecular bond lengths
and angles also comes from crystal-
lography.) The consistency of these
structures with experimental data val-
idates them, and because they have
been validated this way (on the whole)
they can be relied upon.
There are profound physical rea-
sons why computational approaches
to the protein folding problem have
thus far yielded so little solid informa-
tion about the specific details of pro-
tein structures. No matter whether an
initial model for a protein is obtained
by homology modeling or not, it must
be refined to optimize the placement
of residues, and this is done by energy
minimization techniques. The force
fields commonly used to find lowest
energy conformations of macromole-
cules assume that interatomic inter-
actions are pair-wise additive, which
simply untrue. In condensed phases,
polarization phenomena strongly influ-
ence molecular behavior and polariza-
tion energies, which include van der
Waals interactions, are not pair-wise
additive (Maitland et al., 1981). But
even if this notoriously difficult prob-
lem in physical chemistry was solved,
which it may be at some point, the
way forward would still be unclear.
How do you estimate the accuracy
of a protein structure arrived at by
computation? How do you validate a
computed model for a protein’s struc-
ture short of determining its structure
experimentally, and if you are pre-
pared to do that, why bother comput-ing its structure? Thus there are re-
asons for doubting that PSI will ever
bring us to the paradise in which one
needs only the sequence of a protein
to determine its structure. Hello,
Sisyphus!
There are other problems with PSI.
It is remarkable how little you know
about a protein if all you have is its
three-dimensional structure. It is
bound to be a mixture of a helices
and b sheets in some combination, and
they usually pack together to make
a dense, amorphous blob. In fact, if
you have seen a few protein ribbon
diagrams you have seen them all,
and I say this as someone who still re-
members the excitement he felt as
a graduate student in the early 1960s
when he attended a series of lectures
on the crystal structure of hemoglobin
given at Harvard University by Max
Perutz. The fact is that protein
structures come alive intellectually
only when they are connected with
genetic, and/or biochemical, and/or
physiological data indicating what
they do and hinting at how they might
do it. Thus the solving of the structures
of proteins of unknown function simply
because their sequences suggest they
might have novel folds, which is a
major focus PSI activity, is amisguided
activity. Far better to concentrate on
the structures of proteins whose
functional significance is already
clear.
In this regard it is interesting that NIH
has lately begun asking PSI centers to
devote a fraction of their efforts to
solving specific structures in response
to requests made by members of the
wider biological community (http://
www.nigms.nih.gov/News/Reports/psi2_
update_052007.htm). This was not part
of the original plan! This change in di-
rection suggests that over time PSI
centers may morph into protein struc-
ture solving centers that behave a lot
like the DNA sequencing and synthe-
sis centers on which we all depend.
This would be a sorry outcome in-
deed compared to what was originally
promised.
The $60,000,000 a year NIH is
spending on PSI would pay for a lot
of single-investigator RO1 grants. The
rate at which new physiological pro-
cesses are being uncovered by cellStructure 15, November 2007 ª2and molecular biologists today is stun-
ning, and there are lots of young struc-
tural biologists eager to work on them.
NIH would get a lot more for its money
if it used its PSI funds to support sin-
gle investigators who use either X-ray
crystallography or NMR to understand
how macromolecules of known bio-
logical significance work. Those ask-
ing NIH to fund this kind of research
would have to justify their activities
not by the number of new entries
they promised to add to structural da-
tabases, but instead by the biologi-
cal impact of the work they propose.
Thus the biological community would
be assured that each new structure it
‘‘paid for’’ fit into a functional context
that was of known biological signifi-
cance. NIH would reap an additional
benefit by making this change. Single
investigator, problem-driven laborato-
ries are much better places to train
graduate students and postdoctoral
students than factories that churn out
a single kind of data.
The NIHwould also be wise to invest
some of its PSI money in the activities
of physical chemists interested in the
properties of condensed phase mat-
ter. A lot of the best members of that
community do not think about biology
from one year’s end to the next, but
they are the people most likely to solve
the fundamental force field problems
referred to above.
Interestingly, even though research
on force fields might pay dividends,
as far as one can tell, there is little
research of this sort going on in PSI
centers. Instead the staffs at these
centers are working to increase the
speed with which protein structures
can be determined experimentally,
and solving asmany newprotein struc-
tures as possible, as fast as possible,
with preference being given to pro-
teins that by sequence appear likely
to belong to novel fold classes. There
are also efforts underway to perfect
the art of homology modeling, which
could be helpful, but is unlikely to be
decisive by itself for the reasons just
discussed.
If PSI is allowed to carry on, a lot of
new protein structures will get depos-
ited in the protein databases, which
is a good thing, even if we have no
idea what the physiological relevance007 Elsevier Ltd All rights reserved 1351
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solved. Sooner or later, someone
will find out what the orphans do.
More efficient methods for solving
macromolecular structures should
also emerge, which is also a good
thing. Thus in arguing against the con-1352 Structure 15, November 2007 ª200tinuation of PSI, I am not claiming that
the larger community will obtain no
benefits from it at all. What I am claim-
ing is something that seems obvious to
many, but not to everyone—namely,
that the money could be much better
spent.7 Elsevier Ltd All rights reservedREFERENCES
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